| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443256 | European Journal of Cancer | 2014 | 11 Pages |
Abstract
In summary, we identified ADORA2B to be the specific receptor and signalling pathway for the metabolite MTA. These findings may influence the use of MTA in a therapeutic manner.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Katharina Limm, Susanne Wallner, Vladimir M. Milenkovic, Christian H. Wetzel, Anja-Katrin Bosserhoff,